Craig Podolsky

Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022.

Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022.

Conavi Medical, Inc. develops, manufactures, sells, and supports technologies to help guide minimally invasive procedures. It provides imaging devices for use during procedures performed by electrophysiologists and interventional cardiologists. The company was founded by Brian Courtney and Amandeep Thind in 2007 and is headquartered in Toronto, Canada.

Conavi Medical, Inc. develops, manufactures, sells, and supports technologies to help guide minimally invasive procedures. It provides imaging devices for use during procedures performed by electrophysiologists and interventional cardiologists. The company was founded by Brian Courtney and Amandeep Thind in 2007 and is headquartered in Toronto, Canada.

Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022.

Conavi Medical, Inc. develops, manufactures, sells, and supports technologies to help guide minimally invasive procedures. It provides imaging devices for use during procedures performed by electrophysiologists and interventional cardiologists. The company was founded by Brian Courtney and Amandeep Thind in 2007 and is headquartered in Toronto, Canada.

Conavi Medical, Inc. develops, manufactures, sells, and supports technologies to help guide minimally invasive procedures. It provides imaging devices for use during procedures performed by electrophysiologists and interventional cardiologists. The company was founded by Brian Courtney and Amandeep Thind in 2007 and is headquartered in Toronto, Canada.

Conavi Medical, Inc. develops, manufactures, sells, and supports technologies to help guide minimally invasive procedures. It provides imaging devices for use during procedures performed by electrophysiologists and interventional cardiologists. The company was founded by Brian Courtney and Amandeep Thind in 2007 and is headquartered in Toronto, Canada.

Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022.

Contura Ltd. specializes in the distribution and sale of healthcare products, both in pharmaceuticals and medical devices. The firm focuses in the fields of urology and urogynaecology. Its products include bulkamid, cystistat, and aquamid. The company was founded by Henry Geoffrey McMillan in 2000 and is headquartered in London, the United Kingdom.

Contura Ltd. specializes in the distribution and sale of healthcare products, both in pharmaceuticals and medical devices. The firm focuses in the fields of urology and urogynaecology. Its products include bulkamid, cystistat, and aquamid. The company was founded by Henry Geoffrey McMillan in 2000 and is headquartered in London, the United Kingdom.